Actively Recruiting
imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce
Led by University of Sao Paulo General Hospital · Updated on 2025-06-10
61
Participants Needed
1
Research Sites
151 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Pulmonary arterial hypertension (PAH) is a progressive condition with high morbidity, frequent hospitalizations, and risk of right heart failure. Despite advances in treatment, poor adherence remains a major challenge. This randomized controlled study assesses whether remote monitoring can improve treatment adherence, clinical outcomes, and side effect management in PAH patients on oral therapy.
CONDITIONS
Official Title
imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged �3e�3d18 years diagnosed with pulmonary arterial hypertension (PAH) (Group 1 of the WHO classification) - Stable oral PAH therapy (including endothelin receptor antagonists, phosphodiesterase-5 inhibitors, or prostacyclin pathway agents) for at least four weeks prior to enrollment - Ability to participate in remote teleconsultations (access to a phone or internet) - Signed informed consent agreeing to study participation
You will not qualify if you...
- Severe cognitive impairment or psychiatric disorders that could affect adherence or study participation - Inability to communicate via phone or telemedicine due to technical or personal constraints - Concurrent participation in another interventional clinical trial that could interfere with outcomes - Life expectancy <6 months due to any condition unrelated to PAH - Pregnancy or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
InCor - Universidade de São Paulo
São Paulo, São Paulo, Brazil, 05048000
Actively Recruiting
Research Team
C
Caio Fernandes, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here